Perigon Wealth Management, LLC Fibrogen Inc Transaction History

Perigon Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$31.0 - $55.72 $38,688 - $69,538	-1,248 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$37.09 - $48.97 $46,288 - $61,114	1,248 New	1,248 $46,000
Q2 2018 Aug 07, 2018	SELL	$44.9 - $64.95 $69,999 - $101,257	-1,559 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$45.35 - $61.65 $1,814 - $2,466	40 Added 2.63%	1,559 $72,000
Q3 2017 Dec 05, 2017	BUY	$33.4 - $53.9 $50,734 - $81,874	1,519	1,519 $82,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Perigon Wealth Management, LLC with notifications on news.